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time or in living animals, we have also developed a geneti-
cally encoded system to express a modification-specific 
intracellular antibody (mintbody). Transgenic fruit fly and 
zebrafish that express histone H3 Lys9 acetylation-specific 
mintbody developed normally and remain fertile, suggest-
ing that visualizing histone modifications in any tissue in 
live animals has become possible. These live cell modifica-
tion tracking techniques will facilitate future studies on epi-
genetic regulation related to development, differentiation, 
and disease. Moreover, these techniques can be applied to 
any other protein modification, opening up new avenues in 
broad areas in biology and medicine.
Keywords Chromatin · Epigenetics · Posttranslational 
protein modification · Live cell imaging
Introduction
Thanks to the discovery of fluorescent proteins and devel-
opment of live cell microscopy technologies, any protein 
can now be visualized in living cells and in organisms 
(Shaner et al. 2005; Giepmans et al. 2006; Chalfie 2009). 
The expression level of the tagged protein is also adjustable 
to the endogenous level by inserting the tag into the endog-
enous gene locus by homologous recombination (Yang 
et al. 2013). Therefore, the changes in the protein localiza-
tion can be tracked over time in single cells and also dur-
ing development and differentiation in model systems. A 
simple localization analysis, however, cannot distinguish 
molecules that harbor specific function from non-functional 
ones. For example, only a fraction of RNA polymerase II 
(RNAP2) molecules are transcribing genes at a given time, 
while the other molecules may be freely diffusing in the 
nucleus or undergoing repeat binding and unbinding with 
Abstract Protein localization and dynamics can now 
be visualized in living cells using the fluorescent protein 
fusion technique, but it is still difficult to selectively detect 
molecules with a specific function. As a posttranslational 
protein modification is often associated with a specific 
function, marking specifically modified protein molecules 
in living cells is a way to track an important fraction of pro-
tein. In the nucleus, histones are subjected to a variety of 
modifications such as acetylation and methylation that are 
associated with epigenetic gene regulation. RNA polymer-
ase II, an enzyme that transcribes genes, is also differen-
tially phosphorylated during the initiation and elongation of 
transcription. To understand the mechanism of gene regula-
tion in vivo, we have developed methods to track histone 
and RNA polymerase II modifications using probes derived 
from modification-specific monoclonal antibodies. In Fab-
based live endogenous modification labeling (FabLEM), 
fluorescently labeled antigen-binding fragments (Fabs) 
are loaded into cells. Fabs bind to target modifications in 
the nucleus with a binding time of a second to tens of sec-
onds, and so the modification can be tracked without dis-
turbing cell function. For tracking over longer periods of 
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DNA until they become assembled into preinitiation com-
plexes (Kimura et al. 1999, 2002; Stasevich and McNally 
2011). Therefore, one of the next challenges in live cell 
microscopy is to selectively detect protein molecules with 
specific functions, such as enzymatically active molecules 
and ones in specific protein complexes. By using technolo-
gies that can measure protein mobility, including fluores-
cence recovery after photobleaching (FRAP), fluorescence 
correlation spectroscopy and single-molecule tracking, dif-
ferent kinetic fractions (e.g., stable DNA-bound and DNA-
unbound forms; and multimeric and monomeric forms) can 
be detected (Mazza et al. 2012). A few different kinetic 
fractions have successfully been separated by these tech-
niques combined with kinetic modeling and/or simulation, 
but rigorous analyses are required to separate different frac-
tions with similar kinetics and the interpretation relies on 
the models (Darzacq et al. 2007; Stasevich and McNally 
2011). Therefore, it would be ideal if a specific mark for 
functional molecules could be detected in living cells. One 
strategy for detecting a specific form is to monitor a pro-
tein–protein interaction, as many proteins exhibit distinct 
functions in different protein complexes with specific part-
ners. For this purpose, one can use Förster/fluorescence 
resonance energy transfer (FRET), which occurs between 
two spectrally overlapping donor and acceptor fluorophores 
when they are close enough and in the right orientation 
(Sekar and Periasamy 2003). In practice, however, intermo-
lecular FRET is quite difficult to detect, and only limited 
cases are available (Aoki et al. 2012). Another strategy is to 
label a posttranslational modification, as many proteins are 
subjected to a variety of modifications and some are asso-
ciated with protein function. Indeed, antibodies directed 
against specific modifications have in fact been widely 
used to detect functional and/or specific forms of proteins. 
However, it has only recently become possible to use mod-
ification-specific antibodies for live cell imaging (Hayashi-
Takanaka et al. 2009; Kimura et al. 2010).
Posttranslational protein modification plays a critical 
role in gene regulation, as it does in many other important 
biological events, such as signal transduction. Both the 
template chromatin for transcription and the transcribing 
enzyme, RNA polymerase, can be heavily modified (Fig. 1) 
(Bannister and Kouzarides 2011; Eick and Geyer 2013; 
Kimura 2013; Jeronimo et al. 2013), and our approach 
to tracking their modifications in living cells has been a 
breakthrough to fully understand how genes are regulated 
in vivo.
Histone modification and gene regulation
In eukaryotic cell nuclei, genomic DNA is packed into 
chromatin. The fundamental unit of chromatin is called the 
“nucleosome,” a structure containing ~ 150 bp of DNA that 
is wrapped around a histone octamer (two copies of each 
of the core histones, H2A, H2B, H3, and H4) (Luger et al. 
1997). Therefore, many important biological events that use 
























Fig. 1  Schematic illustration of histone and RNAP2 modifications. 
Transcriptionally inactive condensed chromatin harbors inactive his-
tone marks, such as H3K9me2, H3K9me3, and H3K27me3. In con-
trast, transcriptionally active promoter regions are associated with 
active marks, such as H3K4me3 and H3K27ac. RNAP2 phosphoryla-
tion is associated with the transcription cycle. Ser5 and Ser2 along 
the Rpb1-CTD repeat are phosphorylated during the initiation and 
elongation, respectively
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DNA replication, and DNA repair, have to deal with this 
structure. The nucleosome formation has been thought to 
have an inhibitory role in transcription, as transcription 
factor binding is often prevented; however, recent stud-
ies have shown that histones function both positively and 
negatively in the regulation of gene expression (ENCODE 
Project Consortium 2012). Such positive and negative regu-
lations are largely governed by posttranslational modifica-
tions on specific amino acid residues on histones (Fig. 1). 
As histones, particularly H3 and H4, bind quite stably to 
DNA (Kimura and Cook 2001; Kimura 2005), their post-
translational modifications can be inheritable epigenetic 
marks, in addition to direct DNA modifications, which 
are of limited diversity, such as methylation and hydroxy-
methylation on the 5-position at the cytosine base (Smith 
and Meissner 2013). In contrast, histones are subjected to 
a variety of modifications, including acetylation, methyla-
tion, phosphorylation, and ubiquitylation, on many differ-
ent amino acid residues. Among the various modifications 
on four core histones, acetylation and methylation on spe-
cific lysine residues on H3 appear to be most relevant to 
gene regulation (Bannister and Kouzarides 2011; Kimura 
2013). On a lysine residue, the primary amine is positively 
charged, and when single acetylation occurs at the amino 
group, the charge is neutralized. This neutralization could 
loosen the contact between negatively charged DNA and 
lysine-rich histones so that nucleosomal DNA may become 
more accessible to transcription factors. Such loosening 
can be observed by biochemical analysis when massive or 
a critical acetylation occurs (Brower-Toland et al. 2005; Di 
Cerbo et al. 2014), but the information of individual acet-
ylation is also transmitted through a “reader” protein that 
binds to a specific acetyl lysine (Yun et al. 2011). Meth-
ylation on lysine can also occur on the primary amine. As 
each of the three hydrogen on the primary amine can be 
replaced by a methyl group without changing the positive 
charge, three different levels of methylation, monomethyla-
tion (me1), dimethylation (me2), and trimethylation (me3), 
are possible. A number of proteins that bind specifically 
to methyl lysine are also present (Yun et al. 2011). Thus, 
a single lysine residue could have five different modifica-
tion states (i.e., acetyl, unmodified, me1, me2, and me3), 
and specific binding proteins can recognize these specific 
modifications.
Histone H3 is acetylated at K9, K14, K18, K23, and 
K27, and all acetylation is essentially correlated with tran-
scriptional activation. Among them, H3K27 acetylation 
(H3K27ac) is specifically enriched in transcription start 
sites and enhancers of active or potentially active genes 
(Fig. 1) (Kimura 2013). Others, such as H3K9 acetylation 
(H3K9ac) and H3K14 acetylation (H3K14ac), are dis-
tributed more broadly (Karmodiya et al. 2012). The cor-
relation of methylation on H3 with transcription activity 
depends on its level and the residue. Methylation of H3K4 
is associated with transcriptionally active genes. In par-
ticular, trimethylated H3K4 (H3K4me3) is known to be 
a good marker for transcription start sites of transcribed 
genes (Fig. 1) (ENCODE Project Consortium 2012). In 
contrast, methylations on H3K9 and H3K27 are generally 
associated with inactive genes (Fig. 1). However, these 
histone modifications may not be necessarily prerequisite 
codes for turning genes on and off (Henikoff and Shilati-
fard 2011). Some could affect the transcription kinetics, 
and others could be added as a consequence of pioneering 
transcription.
Histone modifications change locally and globally dur-
ing development and differentiation and in response to 
external stimuli. As dysregulation of histone modifications 
is often associated with diseases such as cancer (Portela 
and Esteller 2010; Butler et al. 2012; You and Jones 2012), 
it is important to reveal the function and regulatory mecha-
nism of histone modifications. Whereas the genome distri-
bution of several histone modifications has been measured 
in many different cell types, how these modifications are 
regulated at the single cell level in vivo remains largely 
unknown. Therefore, it has been important to develop a 
method to visualize histone modifications in living cells 
and organism.
RNA polymerase II modification and the 
transcription cycle
RNA polymerase II (RNAP2) is a multi-subunit DNA-
dependent RNA polymerase that transcribes most genes 
and some small noncoding RNA. The catalytic, largest, 
subunit of RNA polymerase II (Rpb1) harbors heptapep-
tide (YSTPSPS) repeats at the C-terminal domain (CTD) 
(Eick and Geyer 2013; Jeronimo et al. 2013). In human 
and mouse Rpb1, this heptapeptide is repeated 52 times 
with slight variations at the latter part of the tail, while 
Rpb1 in lower organisms harbors shorter repeats at the 
CTD (e.g., 27 times in budding yeast). All of the Ser resi-
dues in the heptapeptide (i.e., S2, S5, and S7) are known 
to be phosphorylated, and the phosphorylation on S2 and 
S5 has been well correlated with the RNAP2 transcription 
cycle (Fig. 1). In brief, when RNAP2 is freely diffusing and 
becomes assembled into the preinitiation complex on a pro-
moter, Rpb1-CTD is unphosphorylated. During the initia-
tion, S5 becomes phosphorylated by Cdk7-CyclinH kinase 
in TFIIH. When processive transcription elongation begins, 
S2 becomes phosphorylated by P-TEFb (the complex of 
Cdk9-CyclinT) and by other kinases including Cdk12 
(Bowman and Kelly 2014). Upon removal of RNAP2 from 
the DNA template after the completion of transcription, 
Rpb1-CTD becomes dephosphorylated again. Thus, the 
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phosphorylation states of Rpb1-CTD can be well-defined 
markers for specific forms.
Modification‑specific monoclonal antibodies
To analyze protein modifications, specific antibodies 
have proven very useful (Kimura 2013; Goto and Ina-
gaki 2014). The presence of the target modifications can 
be detected in situ and in cell extracts by immunochemi-
cal techniques, such as immunofluorescence, immunob-
lotting, and immunoprecipitation. In the early 2000s, we 
began to analyze histone modifications using polyclonal 
histone modification-specific antibodies obtained from 
commercial sources. However, we had been often frus-
trated due to the uncertainty of specificity and lot-to-lot 
differences. When using different antibody lots with the 
same catalog number, results of chromatin immunoprecip-
itation (ChIP) were sometimes inconsistent. Our enzyme-
linked immunosorbent assay (ELISA) using synthetic 
peptides that contained residue-specific modifications in 
fact showed that some antibody samples cross-reacted 
with many peptides and had little specificity (Kimura et al. 
2008). We then decided to generate more reliable antibod-
ies. Although there was an argument about whether or not 
monoclonals are better than polyclonals, we chose to gen-
erate monoclonals because, in principle, once good hybri-
doma cells are established, the properties of monoclonal 
antibodies should be retained over time and their supply 
is unlimited. Making histone modification-specific anti-
bodies was not easy work, however, because the specific 
antibodies need to recognize both the difference of the sin-
gle methyl group (e.g., H3K9me3 and H3K9me2) and the 
neighboring amino acids (e.g., H3K9me3 and H3K27me3) 
(Kimura 2013). After spending lots of time and effort to 
screen specific clones (e.g., by ELISA using 46 differ-
ent peptides, immunoblotting, immunofluorescence, and 
ChIP), we have made a panel of specific monoclonal anti-
bodies directed against histone H3 and H4 modifications 
(Kimura et al. 2008; Hayashi-Takanaka et al. 2009, 2011, 
2014; Rechtsteiner et al. 2010; Chandra et al. 2012). These 
antibodies have been used for western blotting, immuno-
fluorescence and chromatin immunoprecipitation in many 
different laboratories, including those involved in the mod-
ENCODE project (Egelhofer et al. 2011) and the Interna-
tional Human Epigenome Project. We have also generated 
monoclonal antibodies directed against unphosphorylated 
and phosphorylated Rpb1-CTD of RNAP2. Importantly, 
these antibodies are also applicable to immunohistochem-
istry using human patient specimen (Yokoyama et al. 
2013, 2014) and immunofluorescence using mouse tis-
sue sections (Eberhart et al. 2012, 2013; Kamiunten et al. 
2014).
Fab‑based live endogenous modification labeling
We thought that the monoclonal antibodies we had gener-
ated might be useful for detecting the target modifications 
in living cells. For that, we first labeled a native antibody 
(as IgG form) with a fluorescent dye and loaded it into 
cells. However, this initial attempt using the whole IgG did 
not work well; cytoplasmically loaded IgG did not enter the 
nucleus because it is bigger than the nuclear pore (Hayashi-
Takanaka et al. 2011). Even though IgG became accessible 
to chromatin during mitosis and entered the nucleus after 
cell division, its high affinity and bivalency could cause 
toxic effects to cells by blocking the target.
In contrast to the whole IgG, fluorescently labeled anti-
gen-binding fragments (Fabs) were suitable for detecting 
the endogenous histone modifications (Hayashi-Takanaka 
et al. 2009, 2011). We prepared Fab fragments from the 
whole IgG by protease digestion and labeled these with 
an amine-reactive fluorescent dye, before loading into liv-
ing cells (Fig. 2, top). After loaded into cells, Fabs diffuse 
throughout the cytoplasm and enter the nucleus through the 
pore by diffusion, as their size (~50–60 kD) was just smaller 
than the pore size. If the target modification is present in 
the nucleus, Fabs bind to the target and become concen-
trated in the nucleus (Fig. 3). Fabs could bind to the target 
modification stably and block the access of cellular factors 
to the modification; however, Fab binding was transient and 
did not interfere with cell division. FRAP revealed that the 
binding time of Fabs to the target modifications in living cell 
nuclei was in a range from <1 to ~30 s, depending on the 
binding affinity. This might be unexpected because antibody 
binding to the epitope is thought to be quite stable. Unlike 
whole IgG that has a bivalent antigen-binding site, Fabs 
are monovalent and the binding affinity is much lower. In 
addition, the high macromolecule concentration (>100 mg/
ml) in living cells can cause more frequent molecular col-
lisions to force the dissociation of bound proteins. Indeed, 
Fabs loaded into cells at ~1 µM did not disturb cell growth. 
Furthermore, mouse preimplantation embryos injected with 
Fab developed normally to birth. It is thus concluded that 
the endogenous modifications can be visualized by using 
fluorescently labeled Fab without affecting cell function. We 
named this technique Fab-based live endogenous modifica-
tion labeling, or FabLEM (Hayashi-Takanaka et al. 2011).
By using FabLEM, simultaneous detection of multiple 
modifications is possible, as fluorescent dyes are directly 
conjugated to Fabs. In principle, any fluorescent dye can be 
conjugated to Fabs, but some dyes interfere with Fab activ-
ity and/or tend to cause cytoplasmic aggregation. A sys-
tematic screening has revealed that Alexa Fluor 488, Cy3, 
and Cy5 or CF640 are the most suitable conjugation part-
ners with Fabs among green, red, and far-red fluorescence 
dyes, respectively (Hayashi-Takanaka et al. 2014). By 
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using multiple Fabs labeled with these dyes, three different 
histone modifications can be visualized simultaneously in 
single cells (Fig. 4). Once loaded into cells, Fab molecules 
are quite stable, and their localization can be followed for a 
few days until the signal becomes too diluted by cell divi-
sion or Fabs are trapped in cytoplasmic vesicles.
FabLEM has been useful to track both the localization 
of modifications and the global modification level in the 
nucleus. For example, the concentration of H3K27me3 on 
inactive X chromosomes can be visualized in living cells 
(Fig. 4), which allowed us to track the intranuclear locali-
zation and replication timing of inactive X chromosomes 
in living cells (Hayashi-Takanaka et al. 2011). The changes 
in global modification levels can be monitored by FRAP or 
by comparing the nuclear/cytoplasmic intensity ratio meas-
urements. When the modification level is increased, more 
Fab molecules become bound to chromatin, and so the dif-
ference in bound fraction and/or on-rate can be measured 
by FRAP. In addition, as unbound Fabs can diffuse into the 
cytoplasm, the ratio of nuclear and cytoplasmic fluores-
cence intensity is correlated with the bound and unbound 
fractions. Therefore, the changes can be detected by simple 
intensity ratio measurements. In these ways, we have been 
able to measure the effect of histone deacetylase inhibitor 
on histone H3 acetylation and methylation in a sensitive 
manner.
Modification‑specific intracellular antibody
Although FabLEM is a powerful technique, it requires puri-
fied Fabs and direct loading into cells, which may prevent 
long-term and high-throughput assays. In vivo analysis using 
model organisms is also limited except just after fertilization 




































Fig. 2  Schematic illustration of FabLEM and mintbody methods. 
Once hybridoma cells that produce specific antibody directed against 
a modification site are generated, two methods for tracking the modi-
fication in living cells are possible. (Top) FabLEM: Modification-
specific antibody is purified from hybridoma cell culture superna-
tant, and fluorescently conjugated Fab fragments are prepared for 
loading into cells or injecting into mouse embryos. (Bottom) Mint-
body: cDNA encoding the variable regions of heavy (VH) and light 
chains (VL) can be cloned into a vector to be expressed as an scFv 
fused with the green fluorescent protein. The expression vector can be 













Fig. 3  Transient binding of Fab to target modifications in living 
cells. Fluorescently labeled Fab molecules that entered the nucleus 
repeatedly bind and unbind to target modifications (e.g., acetylated 
histone H3). The localization of the modification can therefore be 
detected by Fab concentration. The transient binding of Fabs allows 
the access of endogenous proteins to the modification, and thus, Fabs 
have little effects on cell physiology
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To overcome these limitations, we have also developed a 
genetically encoded system using single-chain variable frag-
ments (scFv; Ahmad et al. 2012) tagged with the enhanced 
green fluorescent protein (EGFP). We cloned the scFv cod-
ing sequence from hybridoma cells producing the specific 
antibody against histone H3 Lys9 acetylation (H3K9ac) and 
then genetically fused the scFv with EGFP (Fig. 2, bottom). 
We named the scFv-EGFP probe a modification-specific 
intracellular antibody, or “mintbody” (Sato et al. 2013). The 
H3K9ac-specific mintbody (H3K9ac-mintbody) bound to the 
target acetylation in living cells, and the changes in acetylation 
levels in response to a histone deacetylase inhibitor could be 
monitored by FRAP or the nuclear/cytoplasmic intensity ratio, 
just like FabLEM. Making use of the genetically encoded sys-
tem, we have generated transgenic fruit fly and zebrafish that 
express the H3K9ac-mintbody. Importantly, those transgenic 
Drosophila and zebrafish developed normally and remain 
fertile, indicating that the expression of mintbody at a certain 
level does not affect development and differentiation (Fig. 5).
Although this mintbody strategy can be used for any 
other modification, intracellular expression of scFv is 
quite difficult because of misfolding and aberrant aggrega-
tion (Stocks 2005; Kvam et al. 2010). To obtain functional 
mintbodies, it will be necessary to screen scFv from several 
different hybridoma clones and/or to introduce mutations 
to improve the folding and stability in the cytoplasm, as a 
few amino acid substitutions can affect the functionality of 
mintbody (Sato et al. 2013).
Histone modification and transcription activation 
dynamics revealed by FabLEM and mintbody
We have recently applied the FabLEM technique to meas-
ure the kinetics of RNAP2 in living cells and to quantify the 
effects of histone modifications on transcription (Stasevich 
et al. 2014a, b). As a model system, we used a mouse cell 
line that stably expresses GFP-tagged glucocorticoid recep-
tor (GFP-GR) and harbors a genome-integrated gene array 
consisting of ~200 copies of glucocorticoid-responsive 
promoter (the mouse mammary tumor virus long-terminal 
repeat). Transcription of the gene array can be activated 
by addition of glucocorticoid hormone, which induces 
nuclear translocation of GR for gene activation. After load-
ing Cy3- and Cy5-labeled Fabs that recognize differentially 
phosphorylated forms of RNAP2 and treating cells with 
the hormone, the kinetics of RNAP2 recruitment (unphos-
phorylated), initiation (S5 phosphorylated), and elongation 
(S2 phosphorylated) at the array after GFP-GR accumula-
tion were determined (Fig. 6). Quantitative measurements 
and fitting to mathematical models revealed that the tran-
sition from initiation to elongation is quite efficient at the 
array. This high elongation efficiency was correlated with 
the level of preexisting histone H3K27ac, which appeared 
to be controlled by a balance between p300 histone acetyl 
transferase and histone deacetylase 4 or 7. Thus, H3K27ac 
can alter downstream transcription kinetics by indirectly 
recruiting P-TEFb kinase, in addition to enhancing the 
H3K27me3 H3K9me2 H3K27ac K27me3/K27ac
Fig. 4  Histone modifications in living cells detected by FabLEM. 
Three different Fabs (Alexa Fluor 488-labeled anti-H3K27me3, Cy3-
labeled anti-H3K9me2, and Cy5-labeled anti-H3K27ac) are loaded 
into human hTERT-RPE1 (telomerase-immortalized retina pig-
ment epithelial) cells. Fluorescence images in living cells were col-
lected using a confocal microscope. H3K27me3-specific Fab, plus 
H3K9me2-specific Fab to some extent, is concentrated on the inactive 
X chromosome (arrowhead). H3K27ac-specific Fab is excluded from 
the inactive X chromosome. Bar 10 μm
H3K9ac-mintbody 30hpf
Fig. 5  H3K9-mintbody in zebrafish. Zebrafish expressing H3K9-
mintbody developed normally. A fluorescence image of a zebrafish 
expressing H3K9-mintbody (30 h post fertilization) was collected 
using a confocal microscope. Bar 100 μm
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binding of GFP-GR. This study indicates a mechanism for 
how a histone modification can contribute to the regulation 
of transcription by RNAP2 in living cells (Stasevich et al. 
2014a).
A correlation between histone H3 acetylation and gene 
activation in vivo has also been revealed using Drosophila 
expressing H3K9ac-mintbody. In Drosophila very early 
embryos, H3K9ac-mintbodies distributed nearly homog-
enously, but became concentrated in nuclei when zygotic 
gene activation occurs (Sato et al. 2013). This is consist-
ent with H3 acetylation serving as a positive mark for tran-
scriptional activation.
Concluding remarks
We anticipate that the techniques we have developed 
(FabLEM and mintbody) will be valuable tools for under-
standing the dynamics of histone modifications and tran-
scription in both cell cultures and in vivo. In particular, 
developing a panel of mintbody probes specific to vari-
ous modifications should be encouraged, as the geneti-
cally encoded system is versatile and convenient to use. 
In addition, cells expressing mintbodies will be useful for 
screening and evaluating potential diagnostic inhibitors 
that affect epigenetic modifications. While other techniques 
such as FRET-based sensors can also monitor epigenetic 
regulation in living cells, in particular the balance between 
the modifying and demodifying enzymes, they cannot 
quantify the endogenous modifications themselves even 
though they seem to be suitable for assaying the effects of 
inhibitors (Sasaki et al. 2012). Importantly, our methodol-
ogy can be applied to any other protein modification, open-
ing up new avenues in broad areas in biology and medicine.
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Fig. 6  RNAP2 activation 
kinetics revealed by FabLEM. 
Fluorescence images (top) and 
schematic illustration (bottom) 
showing how RNAP2 activation 
by FabLEM is tracked. After 
addition of dexamethasone 
(Dex), a steroid hormone that 
binds to the glucocorticoid 
receptor (GR), to cell culture 
medium, GFP-GR enters the 
nucleus and accumulates at the 
gene array (top, arrowheads). 
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